Method for treating inflammatory diseases with A.sub.2a adenosin

Details Method for treating inflammatory diseases with A.sub.2a adenosin Method for treating inflammatory diseases with A.sub.2a adenosin

1994-07-11

1999-03-02

Jarvis, William R. A.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514262, A61K 3152

Patent

active

058771808

ABSTRACT:
Agonists of A.sub.2a adenosine receptors are effective for the treatment of inflammatory diseases.

REFERENCES:
patent: 5140015 (1992-08-01), Olsson et al.
patent: 5278150 (1994-01-01), Olsson et al.
patent: 5665754 (1997-09-01), Feldman et al.
G. W. Sullivan, H.T. Carper and G.L. Mandell, "Specific Type IV Phosphodiesterase Inhibitor Rolipram Combined with Adenosine Reduces Tumor Necrosis Factor-.alpha.-Primed Neutrophil Oxidative Activity," Int. J. Immunopharmac., vol. 17, No. 10, pp. 793-803 (1995).

Affiliated with

Also associated with

Rating

Method for treating inflammatory diseases with A.sub.2a adenosin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treating inflammatory diseases with A.sub.2a adenosin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating inflammatory diseases with A.sub.2a adenosin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-423130